The landmark iPrEx study demonstrated the feasibility of taking Truvada for pre-exposure prophylaxis (PrEP). It also demonstrated that success depends on adherence. The trial participants receiving Truvada had a 44% reduced risk of becoming infected overall, but those who were actually taking the medication had a 92% risk reduction.
The iPrEx team have now turned to the question, how often one has to take the pill to remain protected. Testing at 2, 4, and 7 pills a week, they found the minimum number of pills per week is 4.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy